Equities Research Analysts’ upgrades for Tuesday, November 19th:
Aclaris Therapeutics (NASDAQ:ACRS) was upgraded by analysts at BTIG Research from a neutral rating to a buy rating. BTIG Research currently has $8.00 price target on the stock.
Aclaris Therapeutics (NASDAQ:ACRS) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. The firm currently has $7.00 target price on the stock, up from their previous target price of $2.00.
American Water Works (NYSE:AWK) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. UBS Group AG currently has $155.00 target price on the stock, up from their previous target price of $151.00.
Barrett Business Services (NASDAQ:BBSI) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Bank of New York Mellon (NYSE:BK) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating.
Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.
Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.
BioNTech (NASDAQ:BNTX) was upgraded by analysts at Evercore ISI from an in-line rating to an outperform rating. They currently have $125.00 price target on the stock, up from their previous price target of $110.00.
Salesforce (NYSE:CRM) was upgraded by analysts at Erste Group Bank AG from a hold rating to a buy rating.
Comfort Systems USA (NYSE:FIX) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. The firm currently has $525.00 price target on the stock, up from their previous price target of $396.00.
Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Firstsun Capital Bancorp (NASDAQ:FSUN) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. Raymond James currently has $42.00 target price on the stock.
ICF International (NASDAQ:ICFI) was upgraded by analysts at Sidoti from a neutral rating to a buy rating. The firm currently has $185.00 price target on the stock.
Intuitive Surgical (NASDAQ:ISRG) was upgraded by analysts at Erste Group Bank AG from a hold rating to a buy rating.
Intertek Group (LON:ITRK) was upgraded by analysts at Shore Capital to a hold rating.
Newmont (NYSE:NEM) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.
NexPoint Residential Trust (NYSE:NXRT) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Oxford Square Capital (NASDAQ:OXSQ) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Progressive (NYSE:PGR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Prada (OTCMKTS:PRDSY) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating.
Quest Resource (NASDAQ:QRHC) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
QuantumScape (NYSE:QS) was upgraded by analysts at HSBC Holdings plc from a reduce rating to a hold rating. HSBC Holdings plc currently has $5.30 target price on the stock.
Sleep Number (NASDAQ:SNBR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Trip.com Group (NASDAQ:TCOM) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. They currently have $75.00 target price on the stock.
Vishay Intertechnology (NYSE:VSH) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Receive News & Ratings for Aclaris Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
